Warmest congratulations to VALOR Pharmaceuticals on passing the on-site quality audit of Chia Tai Biopharmaceutical’s suppliers!
On November 5, 2018, a team of experts from Chia Tai Bio visited VALOR Animal Pharmaceuticals. In accordance with veterinary drug GMP and relevant regulations and standards, they conducted a two-day on-site quality inspection and review of VALOR Animal Pharmaceuticals’ supplier operations. The aim was to confirm the standardization and effectiveness of the supplier’s quality management system, ensuring the continuity and stability of product supply to meet Chia Tai Bio’s production and product quality needs. The company’s general manager and relevant department heads warmly received the guests and engaged in in-depth discussions and exchanges.
CP Biopharma, a wholly-owned subsidiary of CP Group, is a global biotechnology company deeply rooted in three major areas: animal health, human health, and global health. It has achieved significant results in animal pharmaceuticals, feed additives, pet supplies, active pharmaceutical ingredients (APIs), dietary supplements, food additives, and environmental protection products. Adhering to a holistic industry chain approach, the company uses a “comprehensive and effective” strategy as its core brand strategy to create a differentiated competitive advantage. Through large-scale proven effective products and solutions, it genuinely responds to people’s expectations for a healthy life. Simultaneously, it deeply integrates its brand philosophy into a new expression system, continuously enhancing communication effectiveness and interactive value with customers and the market.
At the meeting, He Yan, the company’s Quality Inspection Director, gave a systematic and comprehensive report on the operation of the company’s production quality management system, the effectiveness of GMP compliance, and continuous improvement measures. Subsequently, relevant personnel from Chia Tai Biotechnology provided detailed explanations on the background and purpose of this audit, work plan, specific requirements, and schedule, laying a solid foundation for the efficient, orderly, and smooth conduct of the subsequent audit work.
Following the meeting, our staff accompanied the expert team from Chia Tai Biotechnology on a site visit to the production plant, gaining a comprehensive understanding of the overall operational status of the equipment and facilities. During the visit, the guests focused on inspecting and evaluating key aspects such as the company’s production equipment, technological processes, raw material warehouses, and finished product warehouses. They also reviewed relevant raw material and finished product inspection records, experimental data comparison and analysis, implementation of biosafety control measures, and supplier qualification documents, demonstrating their strong interest in our quality management system and production standards.
VALOR Animal Pharmaceuticals and Chia Tai Biopharmaceuticals have long maintained a close, stable, and mutually trusting cooperative relationship. Adhering to the corporate philosophy of “Fangtong Creates High-Quality Products, Innovation Leads to Brilliance,” VALOR prioritizes quality and drives development, strictly following GMP standards throughout the entire production process to ensure reliable product quality and efficient, professional service. Looking to the future, VALOR Animal Pharmaceuticals will continue to uphold its original aspirations and strive for excellence, continuously improving its R&D, manufacturing, and comprehensive service capabilities to provide partners and users with more high-quality, safe, and effective health products. The meeting concluded successfully in a frank, friendly, pragmatic, and efficient atmosphere. Representatives from both sides took a group photo, expressing their shared anticipation for deepening cooperation and achieving win-win development at a higher level and in a wider range of fields.
